BioPharma
17 October, 2024 | Thursday | Interview
Breaking Down Portal Fatigue in Cell and Gene Therapy: Insights from TrakCel’s Experts
In this exclusive BioPharma APAC Q&A, Dr. Matthew Lakelin, Co-Founder and Head of Consultancy Services at TrakCel, and Antonios Spanos, Industry Advisor for TrakCel Consulting Services, discuss the growing ...
Lab
22 October, 2024 | Tuesday | News
Thermo Fisher’s Oncomine Dx Target Test Receives FDA Approval to Guide Treatment with Servier’s VORANIGO® for Grade 2 IDH-Mutant Glioma
Oncomine Dx Target Test to Identify Patients Eligible for Servier’s VORANIGO® (vorasidenib) tablet, the only FDA-approved treatment for Grade 2 IDH-mutant glioma Thermo Fisher Scientific, the world l...
BioTech
21 October, 2024 | Monday | Interview
Sanyou Bio CEO Lang Guojun Introduces World’s Largest Super-Trillion Molecule Library
In an interview with Tongxieyi, Sanyou Bio’s CEO Lang Guojun proudly announced the launch of the world’s largest super-trillion molecule library. With over nine years of development, this breakthrou...
Contract Services
22 October, 2024 | Tuesday | News
Samsung Biologics Inks $1.24 Billion Manufacturing Agreement with Leading Asia Pharma
Samsung Biologics (KRX: 207940.KS), a global contract development and manufacturing organization (CDMO), announced a contract manufacturing deal with an Asia-based pharmaceutical company. The disclosed...
Consumer Health
22 October, 2024 | Tuesday | News
Sanofi and CD&R Join Forces to Accelerate Opella’s Growth in Consumer Healthcare
Sanofi and Clayton, Dubilier & Rice (CD&R) announced exclusive negotiations for the transfer of a 50% controlling stake in Opella, Sanofi's consumer healthcare division. With this partnership, Opella is...
White Paper
30 August, 2024 | Friday | Report
New Trials, New Pills—The Pharma Rollercoaster Continues!
Product Spot Light
22 October, 2024 | Tuesday | News
Thermo Fisher’s Oncomine Dx Target Test Receives FDA Approval to Guide Treatment with Servier’s VORANIGO® for Grade 2 IDH-Mutant Glioma
Premium Article
20 September, 2024 | Friday | Opinion
The Role of Policy and Public Health Initiatives in Addressing Women's Cancer Care in Asia
Bio Invest
17 October, 2024 | Thursday | News
Sunbird Bio Secures $14M in New Funding from Eli Lilly and EDBI to Advance Blood-Based Diagnostic Technology for Neurological Disorders
Biopharma APAC Infomercial
Most Read
- Lack of Regular Screening Fuels Rise in Late-Stage Breast Cancer in Hong Kong, New Report Reveals
- BIOCHINA 2025: Connecting Global Innovators with China's Leading Biotech Firms
- Leon Wyszkowski, President of Analytical Services, Discusses Thermo Fisher's Strategic Move: Expanding Bioanalytical Capabilities in Europe with New Sweden Lab
- The Role of Policy and Public Health Initiatives in Addressing Women's Cancer Care in Asia
- Redefining Patient Safety in the Age of Healthtech
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
Editor Picks
